Min Li

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Systemic Sclerosis

Top Venues

Cancer biology & therapy

Cell death & disease

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dong-Jing Cai, Zi-Yu Zhang, Yue Bu, Li Li, Yue-Zhen Deng, Lun-Quan Sun, Cheng-Ping Hu, Min Li
Asparagine synthetase regulates lung-cancer metastasis by stabilizing the β-catenin complex and modulating mitochondrial response. Cell death & disease 13 (6) (2022)
Junjun Li, Yong-Chang Zhang, Li Wang, Min Li, Jianbo Yang, Pan Chen, Jie Zhu, Xiayu Li, Zhaoyang Zeng, Guiyuan Li, Zhaoyang Zeng, James B McCarthy, Bo Xiang, Mei Yi
FOXA1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma. Cell death & disease 13 (8) (2022)
Dongjing Cai, Chengping Hu, Li Li, Shichao Deng, Jing Yang, Han Han-Zhang, Min Li
The prevalence and prognostic value of KRAS co-mutation subtypes in Chinese advanced non-small cell lung cancer patients. Cancer medicine 9 (1) (2019)
Min Li, Cheng-Zhi Zhou, Jin-Ji Yang, Shun Lu, Di Zheng, Jie Hu, Hui Zeng, You Lu, Kai-Hua Lu, Xin-Ru Mao, Han Han-Zhang, Analyn Lizaso, Jun-Yi Ye, Cheng-Ping Hu
The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients. Cancer biology & therapy 20 (8) (2019)
Min Li, Bing-Rong Zhao, Shi-Qing Liu, Jian An, Peng-Bo Deng, Han Han-Zhang, Jun-Yi Ye, Xin-Ru Mao, Shao-Kun Chuai, Cheng-Ping Hu
Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma. Cancer biology & therapy 19 (10) (2018)